State Street(R) SPDR(R) S&P(R) Biotech ETF
Open-end / ETFRegistrant
SPDR SERIES TRUST
Class ticker
Net Assets
$10,734,887,977
Holdings
161
Latest Report
Jun 30, 2026
Net Assets Over Time
Holdings · 161
Export CSV
Showing 1–50
of 161 holdings by value
· page 1 of 4
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
|
State Street Global Advisors
|
857492706 | 630,641,937 | $630,641,937 | 5.87% | Long | STIV | |
| Apogee Therapeutics Inc | APGE | 1,203,674 | $159,763,650 | 1.49% | Long | EC | |
| Moderna Inc | MRNA | 2,164,892 | $151,607,387 | 1.41% | Long | EC | |
| Twist Bioscience Corp | TWST | 1,469,111 | $151,142,140 | 1.41% | Long | EC | |
| Oruka Therapeutics Inc | ORKA | 1,555,002 | $147,989,540 | 1.38% | Long | EC | |
| Kymera Therapeutics Inc | KYMR | 1,272,754 | $145,946,701 | 1.36% | Long | EC | |
| Viking Therapeutics Inc | VKTX | 3,587,998 | $139,967,802 | 1.30% | Long | EC | |
| Praxis Precision Medicines Inc | PRAX | 413,737 | $138,515,010 | 1.29% | Long | EC | |
| Erasca Inc | ERAS | 7,447,165 | $136,432,063 | 1.27% | Long | EC | |
| Revolution Medicines Inc | RVMD | 690,499 | $129,316,653 | 1.20% | Long | EC | |
| Rhythm Pharmaceuticals Inc | RYTM | 1,161,672 | $128,980,442 | 1.20% | Long | EC | |
| CG oncology Inc | CGON | 1,812,932 | $128,808,819 | 1.20% | Long | EC | |
| SELLAS Life Sciences Group Inc | SLS | 8,654,720 | $127,743,667 | 1.19% | Long | EC | |
| Vaxcyte Inc | PCVX | 2,192,112 | $127,427,471 | 1.19% | Long | EC | |
| Dianthus Therapeutics Inc | DNTH | 1,302,913 | $127,007,959 | 1.18% | Long | EC | |
| Cytokinetics Inc | CYTK | 1,484,466 | $126,461,659 | 1.18% | Long | EC | |
| Natera Inc | NTRA | 459,937 | $124,849,899 | 1.16% | Long | EC | |
| Scholar Rock Holding Corp | SRRK | 2,258,236 | $124,202,980 | 1.16% | Long | EC | |
|
Roivant Sciences Ltd
|
000000000 | 3,504,648 | $124,029,493 | 1.16% | Long | EC | |
| Mirum Pharmaceuticals Inc | MIRM | 1,059,206 | $124,001,246 | 1.16% | Long | EC | |
| Cogent Biosciences Inc | COGT | 3,172,989 | $122,794,674 | 1.14% | Long | EC | |
| Ultragenyx Pharmaceutical Inc | RARE | 3,666,868 | $122,436,723 | 1.14% | Long | EC | |
| Travere Therapeutics Inc | TVTX | 2,130,135 | $121,012,969 | 1.13% | Long | EC | |
|
Alkermes PLC
|
000000000 | 2,271,185 | $118,998,738 | 1.11% | Long | EC | |
| Krystal Biotech Inc | KRYS | 318,741 | $118,466,467 | 1.10% | Long | EC | |
| Celcuity Inc | CELC | 1,128,339 | $118,046,826 | 1.10% | Long | EC | |
| Relay Therapeutics Inc | RLAY | 6,304,701 | $117,960,956 | 1.10% | Long | EC | |
| Spyre Therapeutics Inc | SYRE | 1,326,035 | $117,725,387 | 1.10% | Long | EC | |
| TG Therapeutics Inc | TGTX | 2,135,715 | $117,336,182 | 1.09% | Long | EC | |
| Beam Therapeutics Inc | BEAM | 3,376,280 | $115,873,930 | 1.08% | Long | EC | |
| Insmed Inc | INSM | 1,083,724 | $115,546,653 | 1.08% | Long | EC | |
| Protagonist Therapeutics Inc | PTGX | 941,367 | $115,392,767 | 1.07% | Long | EC | |
| Arrowhead Pharmaceuticals Inc | ARWR | 1,407,587 | $114,732,416 | 1.07% | Long | EC | |
| Vera Therapeutics Inc | VERA | 2,650,187 | $113,719,524 | 1.06% | Long | EC | |
| Vertex Pharmaceuticals Inc | VRTX | 228,475 | $113,490,387 | 1.06% | Long | EC | |
| Madrigal Pharmaceuticals Inc | MDGL | 211,251 | $113,431,224 | 1.06% | Long | EC | |
| AbbVie Inc | ABBV | 442,603 | $111,376,619 | 1.04% | Long | EC | |
| Biogen Inc | BIIB | 512,556 | $110,742,849 | 1.03% | Long | EC | |
| PTC Therapeutics Inc | PTCT | 1,357,466 | $110,728,502 | 1.03% | Long | EC | |
| Halozyme Therapeutics Inc | HALO | 1,412,358 | $110,545,261 | 1.03% | Long | EC | |
|
uniQure NV
|
000000000 | 2,396,361 | $110,376,388 | 1.03% | Long | EC | |
| Bridgebio Pharma Inc | BBIO | 1,477,181 | $110,020,441 | 1.02% | Long | EC | |
|
CRISPR Therapeutics AG
|
000000000 | 2,013,860 | $109,835,924 | 1.02% | Long | EC | |
| ImmunityBio Inc | IBRX | 12,496,050 | $109,402,918 | 1.02% | Long | EC | |
| Summit Therapeutics Inc | SMMT | 7,453,137 | $108,592,206 | 1.01% | Long | EC | |
| Ionis Pharmaceuticals Inc | IONS | 1,358,012 | $107,676,771 | 1.00% | Long | EC | |
| Incyte Corp | INCY | 944,922 | $107,116,358 | 1.00% | Long | EC | |
| Amgen Inc | AMGN | 294,863 | $106,775,790 | 0.99% | Long | EC | |
| Neurocrine Biosciences Inc | NBIX | 618,966 | $104,317,435 | 0.97% | Long | EC | |
| Gilead Sciences Inc | GILD | 819,573 | $103,544,853 | 0.96% | Long | EC |